On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Amsterdam Biotherapeutics Unit's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€2.0M · 3 projects
Projects
3 EU-funded projects, newest first. Each links to the official record.
- ATTACKPartner
Adoptive engineered T cell Trials to Achieve Cancer Killing
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€1.1Mtheir share - TARGETAMDPartner
Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€233ktheir share - RAIDSPartner
Rational molecular Assessments and Innovative Drug Selection
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€724ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 2 shared projects
- Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek ZiekenhuisNetherlands · 2 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- The University of ManchesterUnited Kingdom · 1 shared project
- Rheinisch-Westfaelische Technische Hochschule AachenGermany · 1 shared project
- Universite de GeneveSwitzerland · 1 shared project
- University College LondonUnited Kingdom · 1 shared project
- Institut CurieFrance · 1 shared project
- Max Delbrueck Centrum Fuer Molekulare Medizin In der Helmholtz-Gemeinschaft (Mdc)Germany · 1 shared project
- Ospedale San Raffaele SRLItaly · 1 shared project
- Universitaetsklinikum AachenGermany · 1 shared project
- Universidad de NavarraSpain · 1 shared project
- Institut Gustave RoussyFrance · 1 shared project
- Ecrin European Clinical Research Infrastructure NetworkFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- DNA viruses
- cells technologies
- cervical cancer
- gene therapy
- machine learning
- melanoma
- nucleic acids
- ophthalmology
- proteomics
- statistics and probability
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.